---
title: Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor
  kinase inhibitors in patients with acute myeloid leukemia
date: '2025-02-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39945005/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20250213170906&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Not ...
disable_comments: true
---
Not ...